RxDoctor Payments Data

Victoria Lawrence-Burton

Nurse Practitioner · Nashville, TNNPI 1558797415

Payments from drug & device makers

$5,354in general payments, 2019–2025

Across 202 payments — averaging $26.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$3K
  • AbbVie$732
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$301
  • Collegium Pharmaceutical, Inc.$295
  • Tersera Therapeutics LLC$223
  • Curonix LLC$195
  • plus $957 from 22 others

What the payments were for

  • Food & beverage$5,354100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,354 in reported general payments places this provider in the 90th percentile of 2,662 nurse practitioner providers in Tennessee.

See all nurse practitioner providers in Tennessee

Medicare billing

Part B allowed, 2024
$27,748
Medicare patients
36
Services billed
5,936

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen553$18,352
OxycontinOxycodone Hcl15$9,455
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen317$8,621
ZtlidoLidocaine17$6,178
MovantikNaloxegol Oxalate12$4,770
Lidocaine56$4,134
Gabapentin250$3,373
Pregabalin187$3,110
Oxycodone Hcl104$2,198
Buprenorphine12$2,020
Diclofenac Sodium68$1,963
Naloxone Hcl29$1,662
Morphine Sulfate ErMorphine Sulfate82$1,630
Celecoxib28$1,224
Methocarbamol101$1,165

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Scilex Pharmaceuticals Inc.Ztlido$97$6,17817 claims
Hikma Pharmaceuticals USABuprenorphine, Morphine Sulfate$15$2,29324 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,662 nurse practitioner providers in Tennessee.

Other nurse practitioner in Nashville

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →